Answered

Discover the best answers at Westonci.ca, where experts share their insights and knowledge with you. Find reliable answers to your questions from a wide community of knowledgeable experts on our user-friendly Q&A platform. Get detailed and accurate answers to your questions from a dedicated community of experts on our Q&A platform.

An introduction of recombinant DNA technology to pharmaceutical industry did NOT allow for:
a. Improved drug safety
b. High level of drug modification/alteration
c. Mass-production of the biopharmaceuticals
d. Higher average prices of the major biopharmaceuticals
e. All of the above were the consequences of the switch to recombinant DNA technology in pharmaceutical industry

Sagot :

Thank you for your visit. We're committed to providing you with the best information available. Return anytime for more. Your visit means a lot to us. Don't hesitate to return for more reliable answers to any questions you may have. Keep exploring Westonci.ca for more insightful answers to your questions. We're here to help.